牛牛AI助理已提取核心訊息
180 Life Sciences Corp. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Form S-1 Registration Statement, as per a letter dated February 7, 2024. The company has proposed for the Registration Statement to become effective at 11:00 a.m. Eastern Standard Time on February 9, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. The SEC has been asked to take the necessary action to meet the requested timeline. David M. Loev of The Loev Law Firm, PC is the contact person for any inquiries regarding this acceleration request.
180 Life Sciences Corp. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Form S-1 Registration Statement, as per a letter dated February 7, 2024. The company has proposed for the Registration Statement to become effective at 11:00 a.m. Eastern Standard Time on February 9, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. The SEC has been asked to take the necessary action to meet the requested timeline. David M. Loev of The Loev Law Firm, PC is the contact person for any inquiries regarding this acceleration request.
根據2024年2月7日的一封信，180生命科學公司已正式要求美國證券交易委員會（SEC）加快其S-1表格註冊聲明的生效日期。該公司已提議註冊聲明於美國東部標準時間2024年2月9日上午11點生效。該請求是根據經修訂的1933年《證券法》第461條提出的。美國證券交易委員會已被要求採取必要行動以滿足要求的時間表。如果您對本加速請求有任何疑問，PC Loev Law Firm 的 David M. Loev 是聯繫人。
根據2024年2月7日的一封信，180生命科學公司已正式要求美國證券交易委員會（SEC）加快其S-1表格註冊聲明的生效日期。該公司已提議註冊聲明於美國東部標準時間2024年2月9日上午11點生效。該請求是根據經修訂的1933年《證券法》第461條提出的。美國證券交易委員會已被要求採取必要行動以滿足要求的時間表。如果您對本加速請求有任何疑問，PC Loev Law Firm 的 David M. Loev 是聯繫人。
有用
沒用
